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This protocol describes the use of a template-switch anchored reverse transcription-
polymerase chain reaction (RT-PCR) to quantify and characterize all expressed T cell
receptor (TR) gene products within any defined T cell population. The approach is based on
a switching mechanism at the 5'-terminus of the RNA transcript (SMART) (Chenchik, 1998)
and the rapid amplification of cDNA ends (RACE) (Matz et al., 1999), which subsequently
enable the unbiased and linear amplification of rearranged TR-specific transcripts using
primers that bind an anchor sequence and a conserved 3' region within the TR constant (C)
domain. Combined with amplicon subcloning and high throughput sequencing, a
comprehensive dataset is generated that defines all constituent clonotypes and their relative
frequencies within the template pool (Douek et al., 2002). The procedure is optimized for
direct ex vivo analysis, such that in vitro amplification is unnecessary and outgrowth
frequency bias is avoided (Price et al., 2004). Materials and methods are provided for each
of the following steps: (1) isolation of antigen-specific T cell populations for analysis of TR
gene expression; (2) mRNA extraction; (3) cDNA synthesis; (4) cDNA clean-up; (5) PCR
amplification of rearranged TR products; (6) gel extraction and purification of amplicons;
(7) amplicon ligation into TA cloning vector; (8) vector transformation into competent E.
coli; and, (9) colony PCR and sequencing.
1. ISOLATION OF ANTIGEN-SPECIFIC T CELL POPULATIONS FOR
ANALYSIS OF TR GENE EXPRESSION
The success of this protocol depends greatly on high quality mRNA, which in turn depends
greatly on cell preparation and handling. Cells must be isolated viably and not subjected to
fixation buffers or azide; wash steps are best conducted using standard cell medium with a
serum component. If fixation is required for safety reasons, then an alternative protocol
should be followed to preserve RNA template quality (van Bockel et al., 2007). A high
degree of purity (>98%) is essential to prevent the artefactual detection of non-specific
clonotypes and overestimation of clonality. For this reason, high definition flow cytometric
sorting with purity checking is imperative. Other methods for cell enrichment, such as
magnetic beadbased procedures, should be avoided in conjunction with this protocol. In
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addition, detailed phenotypic information can be collected during the flow cytometric
sorting procedure. Specificity can be determined either physically with pMHC multimers
(Chattopadhyay et al., 2008; Wooldridge et al., 2009) or functionally using the detection of
cell surface activation markers after stimulation with the antigen of choice (Casazza et al.,
2006). Clean separation from non-specific background is the primary consideration in the
selection of an appropriate sorting strategy. In all cases, cells should be handled carefully,
processed as rapidly as possible and sorted immediately after surface staining into an RNA
protectant solution. CAUTION: Biosafety practices should be followed rigorously when
working with viable blood or tissues.
Materials
Single cell suspension of live T cells defined with an appropriate staining procedure
RNAlater (Applied Biosystems)
1.5 ml polypropylene O-ring microcentrifuge tubes (Sarstedt)
Flow-cytometric cell sorter
Microcentrifuge
Procedure
1. Sort T cells (up to 10,000) directly into a 1.5ml polypropylene O-ring
microcentrifuge tube containing 100 µl RNAlater. For greater cell numbers,
additional aliquots of up to 10,000 cells should be sorted to prevent excessive
dilution of the RNAlater; alternatively, cells can be sorted into 100 µl of standard
cell medium or PBS, pelleted and layered with RNAlater after aspiration of the
supernatant. To minimize sampling bias, at least 500–1,000 cells should be
collected for each analysis.
2. Vortex gently or flick the tube to mix, and then spin at 14,000 rpm in a
microcentrifuge for 30 sec to collect all cells in the RNAlater solution. Freeze
immediately and store at −80°C.
2. mRNA EXTRACTION
Purification of mRNA is carried out using the Oligotex Direct mRNA Mini Kit (Qiagen),
with small alterations to the manufacturer’s protocol. This method is based on the isolation
of pure polyadenylated RNA (polyA+ RNA) from cell lysates in an RNase-free environment
using particles coated with oligo(dT), which binds to the polyA+ tail. The beads are then
used to pull down the mRNA for washing.
Materials
QIAshredders with spin columns (Qiagen)
β-mercaptoethanol (BME; Sigma-Aldrich)
Frozen vial of sorted cells in RNAlater (Applied Biosystems)
1.5 ml polypropylene O-ring microcentrifuge tubes (Sarstedt)
Oligotex Direct mRNA Mini Kit (Qiagen)
Buffer OL1 (lysis buffer)
Buffer ODB (dilution buffer)
Buffer OW1 (wash buffer 1)
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Buffer OW2 (wash buffer 2)
Buffer OEB (elution buffer; incubate at 70°C)
Oligotex suspension (incubate at 37°C)
Spin columns
Microcentrifuge
Two heating blocks or thermomixers (37°C, 70°C)
Freezer
Procedure
1. Prepare reagents for later steps: (i) heat Oligotex bead suspension to 37°C in a
heating block, vortex and place at room temperature; (ii) incubate buffer OEB in a
70°C heating block; (iii) for every 2 samples, add 30 µl of BME to 1 ml of buffer
OL1.
2. Partially thaw the sample and centrifuge immediately at 14,000 rpm for 7 min at
4°C. There should be a whitish pellet, containing both cells and salts. Remove
supernatant immediately, leaving the pellet and a minimal residual volume.
3. Add 0.4 ml of buffer OL1 (containing BME) to the pelleted white precipitate and
vortex for 20–30 sec.
4. Pipette the lysate on to a QIAshredder spin column placed in a 2 ml collection tube
and centrifuge for 2 min at 14,000 rpm. Discard spin column and pipette flow-
through into a new 1.5 ml tube.
5. Add 0.8 ml of buffer ODB to the lysate and vortex thoroughly.
6. Vortex Oligotex suspension thoroughly and add 20 µl to the sample. Vortex
thoroughly and incubate at room temperature for 10 min to hybridize the oligo dT30
on the beads with the polyA+ RNA.
7. Centrifuge for 5 min at 14,000 rpm to pellet the beads. Carefully remove and
discard the supernatant, leaving a residual volume of approximately 10–20 µl with
the pellet.
8. Add 350 µl of buffer OW1 and vortex thoroughly for 30 sec to resuspend the
beads.
9. Pipette the sample on to a small spin column placed in a 1.5 ml tube without
touching the bottom of the column. Centrifuge for 1 min at 14,000 rpm. Discard the
collection tube containing the flow-through.
10. Transfer the spin column into a new 1.5 ml collection tube. Pipette 350 µl of buffer
OW2 on to the column. Centrifuge for 1 min at 14,000 rpm. Discard the collection
tube containing the flow-through. Repeat this step.
11. Transfer the spin column into a new 1.5 ml tube and place in a 70°C heating block.
Pipette 20 µl of hot (70°C) buffer OEB on to the column. Pipette up and down
several times to resuspend the beads, taking care not to break the membrane.
Centrifuge for 1 min at 14,000 rpm.
12. To ensure maximal yield, incubate the tube again for 1 min at 70°C and pipette the
same 20µl of hot eluate from step 11 on to the column. Pipette up and down several
times to resuspend the beads as above. Centrifuge for 1 min at 14,000 rpm. Discard
the column.
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13. Proceed to cDNA synthesis immediately and store the remaining mRNA at −80°C.
3. cDNA SYNTHESIS
This section describes the synthesis of cDNA with anchor sequence incorporation. The
method is based on the template-switching ability of RNAse H- point mutants of MMLV
reverse transcriptase (Figure 1).
Materials
PolyA+ mRNA
1.5 ml polypropylene O-ring microcentrifuge tubes (Sarstedt)
5’CDS oligo(dT) primer (10 µM): 5’-(T)25XY-3' (X=A, C, G; Y= A, C, G, T)
SMART II anchor oligo (10 µM): 5 ’-
AAGCAGTGGTATCAACGCAGAGTACGCGGG-3’ containing three G
ribonucleotides (not dG) at the end
5× RT buffer: 250 mM Tris-HCl (pH 8.3), 375 mM KCl and 30 mM MgCl2
Dithiothreitol (DTT, 20 mM; Invitrogen)
Tricine buffer: 10 mM Tricine-KOH (pH 8.5), 1.0 mM EDTA
dNTP mix (10 mM; Invitrogen)
RNAseOUT (RNAse inhibitor; Invitrogen)
Superscript II RNAse H− Reverse Transcriptase (RT, 200U/µl; Invitrogen)
Microcentrifuge
Two heating blocks (42°C, 70°C)
Freezer
The SMARTer™ PCR cDNA Synthesis Kit (Clontech) contains several components
required for cDNA synthesis, including a proprietary modified SMART oligo, which can be
successfully used in this method. However, the 5’CDS oligodT should be synthesized as
described above. The 5' PCR primer II A from the SMARTer™ PCR cDNA Synthesis Kit
(Clontech) can be used as an alternative to the Universal Primer Mix in Section 5 – PCR
amplification of rearranged TR products.
Procedure
1. Before starting, turn the heating blocks to 42°C and 70°C, respectively. Keep
enzymes frozen until just before use.
2. Add the following reagents in the order listed into a 1.5 ml tube:
5’CDS 1 µl
SMART II oligo 1 µl
mRNA 3 µl
3. Place the tube in the 70°C heating block for 1 min (to break any double strands)
then at −20°C for 1 min (to anneal).
4. Add: 5× RT Buffer 2.2 µl
DTT 1 µl
RNAseOUT 1 µl
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dNTP mix 1 µl
Superscript II RT 1 µl
5. Vortex, spin briefly (30 sec at 14,000 rpm) and place in the 42°C heating block for
2 hr.
6. Spin briefly at top speed, then add 10 µl of Tricine buffer and mix gently with a
pipette.
7. Place in a heating block at 72°C for 7 min (to deactivate RT), then spin briefly at
top speed.
Approximately 20 µl of cDNA is made; it can be stored at −80°C or used immediately in the
clean-up procedure prior to PCR.
4. cDNA CLEAN-UP
In the NucleoSpin® Extract II procedure, cDNA binds to a silica membrane in the presence
of chaotropic salt added by the NT binding buffer. The binding mixture is loaded directly on
to NucleoSpin® Extract II Columns. Contaminants, such as salts and soluble
macromolecular components, are removed by a simple washing step with ethanolic wash
buffer NT3. Pure cDNA is finally eluted under low ionic strength conditions with the
slightly alkaline elution buffer NE (5 mM Tris-HCl, pH 8.5).
Materials
cDNA
≥ 99.5% ethanol
1.5 ml polypropylene O-ring microcentrifuge tubes (Sarstedt)
DNase/RNase-free water, molecular biology grade (Sigma)
1.5 ml Eppendorf tubes
NucleoSpin® Extract II kit (Clontech):
Buffer NT
Buffer NT3 (requires addition of 24 ml ethanol)
Buffer NE
NucleoSpin® Extract II Column with clear collection tube
Microcentrifuge
Procedure
1. Adjust DNA binding conditions by dissolving the cDNA in buffer NT and H2O in
the following volumes:
20 µl cDNA
11.4 µl buffer NT
68.6 µl H2O
2. Pipette the 100 µl sample on to the binding column. Spin the column at 10,000 rpm
for 1 min to bind cDNA to the column membrane. Remove and discard flow-
through from the collection tube by pipetting. Replace the column in the same
collection tube.
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3. Pipette 600 µl of NT3 buffer on to the column. Keep the NT3 bottle closed as much
as possible to avoid ethanol evaporation. Spin at 10,000 rpm for 1 min to wash the
cDNA. Remove and discard flow-through from the collection tube by pipetting.
Replace the column in the same collection tube.
4. Spin the empty tube at 10,000 rpm for 2 min. Residual NT3 buffer will collect at
the bottom of the tube. Remove column from the collection tube and place in a 1.5
ml Eppendorf.
5. Add 25 µl of NE buffer directly on to the center of the column and incubate at
room temperature for 1 min. Spin at 10,000 rpm for 1 min to elute the cDNA.
5. PCR AMPLIFICATION OF REARRANGED TR PRODUCTS
Touchdown PCR is performed on clean single-stranded cDNA using TRC-specific and
anchor-complementary primers. The TRC-specific primers are designed to enable optimal
sequencing across the CDR3 including unequivocal identification of the proximal J region.
In the protocol described below, the human TRBC primer MBC2 is used; this primer binds
both C1 and C2. Universal primer mix contains two oligonucleotides of different lengths
that allow an initial specific extension from the adapter to reduce subsequent non-specific
binding. The PCR product is then run on a 1% agarose gel with a 100 bp DNA ladder and
excised. Bands containing amplified TR genes are 500–700 bp in length.
Materials
cDNA (stored at −80°C)
1.5 ml polypropylene O-ring microcentrifuge tubes (Sarstedt)
0.2 ml PCR tubes
10× UPM (Universal Primer Mix)
MBC2 primer (25 µM)
Advantage®2 PCR Kit (Clontech):
10× PCR buffer
AdvanTaq2 (a mixture of two enzymes, polymerase and proofreading)
PCR-grade water
dNTP mix (10 mM)
SYBR Gold (Invitrogen)
UltraPure Agarose (Invitrogen)
TAE buffer
Disposable scalpel
Microcentrifuge
UV illuminator or blue light transilluminator
Thermocycler
Gel box/thick combs/power source
The Advantage®2 PCR Kit contains all necessary reagents except the TRC-specific primer
and the 10× UPM. In this protocol, MBC2 is used for illustration; all TRC-specific α and β
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primer sequences for mouse, macaque and human are detailed in Table 1. The 10× UPM can
be prepared by mixing the following primers at the indicated concentrations:
Long (0.4 µM): 5’-CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT
Short (2 µM): 5’-CTAATACGACTCACTATAGGGC
Procedure
1. Make a PCR mastermix of all reagents except for template in a 1.5 ml
microcentrifuge tube. Mix well by pipetting when adding the water. Sufficient
mastermix should be made to cover all samples, one negative control (water instead
of template) and one extra tube (to account for pipetting error). The volumes for
one sample are shown below:
10× PCR buffer 5 µl
10× UPM 5 µl
MBC2 primer 1 µl
dNTP mix 1 µl
cDNA 7–13 µl
AdvanTaq2 1 µl
Water to total 50 µl (depending on template volume)
2. Mix cDNA template with mastermix in a thin-walled 0.2 ml PCR tube with a
pipette. Spin briefly; do not vortex.
3. Run reactions in a thermocycler under the following conditions:
For 1 cycle: 95°C 30 sec
For 5 cycles: 95°C 5 sec
72°C 2 min
For 5 cycles: 95°C 5 sec
70°C 10 sec
72°C 2 min
For 30 cycles: 95°C 5 sec
68°C 10 sec
72°C 2 min
4. Load and run the entire product with a 100bp DNA ladder on a 1% agarose gel
made with 1× TAE buffer (UNIT 10.4). Leave an empty well between each sample
to minimize the chances of cross-contamination. Stain the gel with SYBR Gold and
visualize with low intensity UV light or a blue light transilluminator, which
minimizes DNA mutagenesis. There should be a bright band in the 500–700 bp
range.
5. Carefully excise the band of interest using a scalpel. Avoid taking excess agarose.
Transfer the gel to a clean 1.5 ml microcentrifuge tube.
6. GEL EXTRACTION AND PURIFICATION OF AMPLICONS
Amplified TR products are extracted from the gel and cleaned up for sub-cloning.
Materials
Gel-bound PCR product
≥ 99.5% ethanol
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1.5 ml polypropylene O-ring microcentrifuge tubes (Sarstedt)
1.5 ml Eppendorf tubes
NucleoSpin® Extract II kit (Clontech):
Buffer NT
Buffer NT3 (requires addition of 24 ml ethanol)
Buffer NE
NucleoSpin® Extract II Column with clear collection tube
Microcentrifuge
Thermomixer (50°C)
Procedure
1. Weigh the 1.5 ml conical tube containing your gel-bound PCR product and subtract
the weight of an empty tube. The gel piece should weigh from 100 mg to 500 mg.
2. Dissolve the gel by adding NT buffer to the 1.5 ml tube containing the gel piece.
Add 2 volumes of NT buffer for every 1 volume of gel (i.e. add 200 µl buffer per
100 mg gel). Incubate the tube in a thermomixer at 50°C/750 rpm for 10 min. If
any solid phase remains visible after this period, vortex periodically and incubate
for a few more minutes.
3. Pipette up to 600 µl of the NT solution on to the binding column. Spin the column
at 10,000 rpm for 1 min to bind DNA to the column membrane. If the volume is
more than 600 µl, repeat this step. Discard flow-through from the collection tube by
pipetting. Replace column in the same collection tube.
4. Proceed as for cDNA clean-up above (section 4, steps 3–5).
7. AMPLICON LIGATION INTO TA CLONING VECTOR
Amplicons are ligated into plasmids designed to capture adenine overhangs for sub-cloning
and sequencing.
Materials
Gel-extracted PCR product
pGEM-T Easy Vector System I kit (Promega), containing pGEM vector, T4 DNA
ligase, 2× ligation buffer #1 and control insert
1.5 ml polypropylene O-ring microcentrifuge tubes (Sarstedt)
DNase/RNase-free water, molecular biology grade (Sigma)
Microcentrifuge
Refrigerator
Procedure
1. For experimental samples, add the following reagents in a 1.5 ml microcentrifuge
tube: 5 µl gel-extracted DNA product, 1 µl pGEM-T Easy vector, 1.5 µl T4 Ligase
and 7.5 µl 2× buffer #1. Set up a negative control tube using 5 µl water in place of
the DNA product and a positive control using 2 µl of control insert and 3 µl water.
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2. Vortex and spin briefly, then incubate overnight (12–18 hrs) at 4°C. Shorter
incubations can be performed, but efficiency is generally suboptimal.
3. Proceed to transformation; residual ligation products can be stored at −20°C.
8. VECTOR TRANSFORMATION INTO COMPETENT E. coli
The pGEM-T Easy vector contains an ampicillin resistance gene; thus, only transformed
bacterial colonies will grow on agar plates in the presence of ampicillin. Blue/white colony
screening is used to identify transformants that contain insert-positive vectors; these appear
white due to insertional inactivation of the beta-galactosidase gene in the vector.
Materials
Ligation product
Transformation-competent, ampicillin-sensitive E. coli cells (e.g. Max Efficiency DH5α
Competent Cells; Invitrogen)
SOC medium (Invitrogen)
LB agar plates containing 100 µg/ml ampicillin, 50 µg/ml isopropyl β-D-1-
thiogalactopyranoside (IPTG) and 50 µg/ml X-galactosidase (X-gal)
1.5 ml polypropylene O-ring microcentrifuge tubes (Sarstedt)
Bench ethanol
Bunsen burner
Plate spinner
Glass spreader
Thermomixer (37°C)
Heating block (42°C)
Procedure
1. Pipette 7.5 µl of each ligation reaction, including positive and negative controls,
into separate 1.5 ml microcentrifuge tubes. A PUC19 plasmid control may also be
transformed to act as a control for bacterial viability.
2. Thaw E. coli cells gently on ice, taking care not to agitate. Gently tap the vial of E.
coli cells to mix, then pipette 50 µl into each tube. Gently flick the mixture; do not
mix by pipetting as competent cells are highly sensitive to shear stress and heat.
Incubate on ice for 30 min to allow DNA to adhere to the bacteria.
3. Heat-shock the E. coli cells by placing in a 42°C heat block for 50 sec to enhance
plasmid uptake. Place the samples on ice for 2 min.
4. Using sterile technique, add 950 µl of SOC medium (room temperature) to each
tube. Replace the caps loosely on the sample tubes and incubate in a thermomixer
at 37°C/750 rpm for 2 hr.
5. Set up Bunsen burner, plate spinner, glass spreader and beaker containing ethanol.
Place a labeled LB plate on the plate spinner. Flame a pipette tip and transfer 200
µl of the bacterial culture on to the LB plate. Flame the glass spreader in ethanol
and allow it to cool for a few seconds. Spread bacteria evenly over the surface of
the LB plate using the glass spreader while rotating the plate spinner several times.
Repeat for each sample.
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6. Incubate LB plates inverted at 37°C overnight (16–24 hrs). Expect ~100 colonies to
form. Blue colonies are negative and white colonies contain inserts. Plates can be
stored for up to 4 weeks at 4°C.
9. COLONY PCR AND SEQUENCING
Single bacterial colony plasmid inserts are amplified in a 96-well plate format using primers
flanking the insertion site. White colonies contain the insert and should be selected for
amplification and sequencing. It is important to pick only single colonies and to avoid
splashing between wells.
Materials
Transformation plates
Sterile toothpicks
Sterile plastic disposable reservoir enabling multi-channel pipette access (Costar,
Corning Inc.)
LB plate containing ampicillin, IPTG and X-gal as above
Platinum Taq DNA Polymerase High Fidelity (HiFi; Invitrogen) with 10× HiFi buffer
and MgSO4 (50mM)
dNTP mix (10 mM; Invitrogen)
M13F and M13R primers, 5 µM each (M13F: 5'-TTTTCCCAGTCACGAC-3'; M13R:
5'-CAGGAAACAGCTATGAC-3')
DNase/RNase-free water, molecular biology grade (Sigma)
15 ml polypropylene tube
Skirted 96-well PCR plate (AB1000, Applied Biosystems)
Snap caps (MicroAmp 8-strip cap; Applied Biosystems)
Cap installing tool (Applied Biosystems)
Aluminum foil seals (Seal & Sample; Beckman Coulter)
Benchtop centrifuge
Thermocycler
Procedure
1. After overnight incubation, check negative (few blue colonies only) and positive
(mostly white colonies) control plates and discard.
2. Prepare PCR mastermix for each required plate in a 15 ml polypropylene tube by
adding the reagents as follows to cover 100 reactions:
10× HiFi buffer 250µl
MgSO4 100 µl
dNTPs 50 µl
M13F primer 100 µl
M13R primer 100 µl
HiFi Taq 14 µl
Water 1,886 µl
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3. Pour the PCR mastermix into a sterile reservoir and pipette 25 µl into each well of
a 96-well PCR plate by using a multi-channel pipette.
4. Move to a laboratory space outside the dedicated PCR room.
5. Draw a 96-well grid on an LB plate and label with date and sample identification
code; this plate is termed the restreak plate.
6. Place the PCR plate on ice. Harvest individual white colonies by spearing with a
sterile toothpick. Make a gentle imprint on the restreak plate, then place the
toothpick in the first well of the PCR plate and twirl it around to dislodge the
bacteria. Continue with separate colonies for each of the remaining wells. Pick one
dark blue colony (plasmid without insert) as a control in the last well.
7. Place the restreak plate in 37°C incubator overnight, then store at 4°C.
8. Place snap-cap lids on the plate, taking care not to touch the insides of the lids. Seal
tight using the cap installing tool.
9. Briefly vortex the PCR plate and centrifuge at 1,000 rpm for 30 sec to bring down
any splashes from the sides of the wells.
10. Run the PCR in a thermocycler as follows:
For 1 cycle 95°C 5 min
For 35 cycles 95°C 30 sec
57°C 30 sec
68°C 3 min
HOLD 4°C
11. Once the PCR programme is completed, remove the plate from the thermocycler
and spin at 1,000 rpm for 1 min to pull down any condensation.
12. Carefully remove the snap-cap strip from the first column and discard. Add 25 µl of
DNase/RNase-free water to each well with a multi-channel pipette and mix well by
pipetting up and down. Using the same tips, transfer 25 µl of the diluted PCR
product to a new 96-well plate.
13. Repeat this process for the entire plate. Place an aluminium foil seal securely on
one plate and store at −20°C until ready to sequence. The other plate serves as a
back-up in case sequencing problems occur and is also used to check that the PCR
worked.
14. Run 5 µl of several individual products from the back-up plate on an agarose gel to
assess the efficiency of amplification (Figure 2). If the colony PCR failed, then
perform a new PCR using colonies from the restreak plate. Seal the plate as above
and store at −20°C
15. Send the one plate per sorted T cell population for Sanger sequencing at a high
throughput facility. Use the insert-specific TRC primer for sequencing. Sequencing
facilities vary in their template requirements and procedures for clean-up, so check
local specifications and adjust accordingly.
Sequences can be aligned, checked and compiled manually using specific analysis software
such as Sequencher (Gene Codes Corporation). Any samples with base ambiguities or
sequence quality <80% should be discarded. Sequences encoding pseudogenes, frame-shifts
or premature stop codons should also be excluded from the analysis; the latter two scenarios
originate from non-productive rearrangements that can maintain basal levels of expression.
In addition, erroneous sequences (e.g. GIRLS or GINAEYA) can arise from the universal
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primer; these should similarly be disregarded. A minimum of 50 functional sequences
should be compiled per sorted T cell population. In all cases, chromatograms should be
checked visually. The V and J gene segments are identified from their 3' and 5' ends,
respectively, using the tables from http://imgt.cines.fr/. As an alternative, the concatenated
sequences can be exported as a FASTA file into IMGT/V-QUEST, which can identify the V
and J segments. The CDR3 should be displayed as a sequence, as TRBD gene usage is
difficult to assign due to N-diversity. Grouped sequences can then be ordered according to
their frequency, which reflects the original clonotypic hierarchy in the sorted T cell
population due to the linear and unbiased nature of the initial PCR. Further details on
bioinformatics tools can be found in Appendix 1W.
COMMENTARY
Background Information
The αβ T cell receptor (TR) is a membrane-anchored heterodimer expressed on the surface
of T cells that mediates specific recognition of antigen in the form of major
histocompatibility complex (MHC) molecules presenting endogenously-derived peptides
bound in the α1α2 groove. Surface expression of such peptide-MHC (pMHC) antigens
provides a display library that enables T cells to detect abnormal intracellular processes
through TR-mediated surveillance, which in turn is the pivotal event that dictates the
initiation of a T cell response. Each α and β chain comprises three hypervariable
complementarity-determining regions (CDRs), which determine the antigen specificity of
the heterodimeric TR. Three mechanisms govern the generation of diversity within the TR
repertoire that is necessary to recognize the myriad potential antigenic peptides that a host
may encounter (Nikolich-Zugich et al., 2004). First, each TR chain is formed by the genetic
rearrangement of variable (V), diversity (D; β chain only) and joining (J) germline gene
segments, which vary in number between species, with a TRC gene. Second, nucleotide
insertions and deletions at the V(D)J junctions (N-diversity) provide an additional level of
variability within the CDR3 of each chain; the CDR1 and CDR2 regions are germline-
encoded by the V genes. Third, pairing of individual α and β chains further amplifies the
potential number of TRs that can be generated. After thymic selection, which operates to
ensure a degree of MHC bias and delete autoreactive TRs, it has been estimated that
approximately 2.5 × 107 unique human (Arstila et al., 1999) and 2×106 murine (Casrouge et
al., 2000) TRs populate the periphery and are available to respond to antigenic challenges.
However, these numbers are dwarfed by the potential number of antigenic pMHC
combinations. By necessity, then, an intrinsic degree of cross-reactivity is incorporated
within the TR recognition system to enable sufficient coverage and also to increase the
likelihood that a given antigen will be recognized by a cognate TR within a time frame that
facilitates an effective response (Mason, 1998). Thus, an individual clonotype, i.e. a T cell
defined by the singular expressed TR, can recognize multiple ligands; similarly, individual
pMHC ligands can productively engage multiple TRs. As a consequence, any antigen-
specific T cell response can comprise multiple clonotypes, which in turn dictate the
functional qualities of the T cell population. The role of this protocol is to enable the
accurate and quantitative analysis of constituent clonotypes within T cell populations
specific for defined antigens. A detailed understanding of clonal selection within the
memory and effector T cell pools is essential to further our understanding of the factors that
influence effective T cell immunity and has direct implications for the rational design of
vaccines and immunotherapies (Appay et al., 2008; Price et al., 2009).
Critical Parameters and Troubleshooting
Meticulous attention to detail is essential for the successful and reliable application of this
protocol. Reagents should be DNase/RNase-free and PCR-grade plastics should be used
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throughout. Dedicated hoods in a "clean room" free from high copy number plasmids should
be used for mRNA extraction, cDNA synthesis and PCR set-up. Benches and pipettes
should be cleaned with 10% bleach solution and an RNase-inactivator (e.g. RNase AWAY;
Sigma-Aldrich) both before and after each procedure to minimize contamination. Disposable
sleeves and gloves should be used throughout. Refer to UNIT 10.20 for detailed
recommendations on optimal work practices in a molecular biology laboratory.
Template purity and quality
As discussed in section (1) above, this protocol is entirely dependent on the isolation of
good quality RNA from viable, healthy and pure T cell populations. The sequence output,
due to its sensitivity and linearity, will reflect the nature of the starting template. Thus,
erroneously captured T cells will lead to the overestimatation of clonality and diversity.
Similarly, exclusion of specific T cells, for example due to antigen-induced cell death, can
lead to the loss of true clonotypes from the starting template and subsequent underestimation
of clonality and diversity.
Sampling issues
Related to template quality, adequate sampling of the repertoire under investigation is
necessary to ensure reproducibility. Thus, as many cells as possible should be sorted from
the initial pool of T cells and the number of sequences generated should reflect the
heterogeneity of constituent TRs within the pool. In practice, based on empirical replicate
analyses, adequate sampling is achieved for largely oligoclonal pMHC tetramer-sorted T
cell populations with >500 cells and >50 sequences. These minimal guidelines should be
adjusted, however, according to the nature of the population under investigation. Thus,
lower frequency clonotypes will be detected as more sequences are generated; however, the
intrinsic sequence error rate will limit the reliable detection of very low frequency
clonotypes. Sequence comparisons should account for such issues (Venturi et al., 2008a;
Venturi et al., 2007).
Unsuccessful PCR amplification
If the 5'-RACE PCR does not generate bands of the expected size, repeat the procedure
using more cDNA (e.g. 13 µl). Further cDNA can be made from the stored RNA for
additional attempts. However, unsuccessful amplification generally reflects a poor starting
template, in which case RNA concentration can be useful (see below). Do not use additional
PCR cycles or nested approaches to amplification, as these procedures increase the error
rate.
Materials
Microcon Centrifugation Filters (Millipore)
DNase/RNase-free water, molecular biology grade (Sigma)
Microcentrifuge
Procedure
1. Bring the remaining mRNA up to 20 µl with water.
2. Place the Microcon filter into a collection tube and add the sample to the red side of
the column. This contains a glycerol-coated filter that allows solutes and fluid
through, but retains the RNA.
3. Close the lid and spin at 14,000 rpm for 3 min.
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4. Transfer the Microcon filter to another clean collection tube.
5. Add 6 µl of water to the red side.
6. Flip over the filter into the collection tube so that the red side is now facing the
bottom of the tube.
7. Spin the filter and collection tube for 3 min at 3,300 rpm. The concentrated mRNA
is now in the collection tube.
8. Use all 6 µl of mRNA for cDNA synthesis, doubling reagent volumes accordingly.
Poor transformation efficiency
If the 5'-RACE PCR gave a distinct band of the expected size but few bacterial colonies
contained an insert, product may have been lost during gel extraction. Most notably, ensure
that buffer NT3 contains the appropriate quantity of ethanol; this can be reduced due to
differential evaporation after reconstitution, especially if the bottle is opened frequently.
Ligation efficiency can also be compromised due to loss of adenine overhangs if the PCR
product is not processed promptly; thus, always proceed to ligation as quickly as possible
once the 5'-RACE PCR is completed. Finally, the quality of the competent bacteria should
be verified.
Anticipated Results
This protocol allows the rapid and comprehensive analysis of all expressed TRs within any
given T cell population and offers significant advantages over previous approaches (Rufer,
2005). Multiple facets of TR usage can be assessed depending on the particular issues under
investigation. Indeed, fundamental aspects of T cell immunobiology have already been
illuminated with this approach (Davenport et al., 2007; Venturi et al., 2008b). It should be
noted that allelic exclusion does not operate at the α locus; thus, clonotypic assessment is
defined by molecular analysis of TRB gene products.
Time Considerations
With experience and good organization, samples can be processed from mRNA extraction to
overnight ligation in one day. An approximate time-guide is: mRNA extraction, 90 min;
cDNA synthesis and clean-up, 3 hr; RACE-PCR amplification of rearranged TR products, 2
hr 45 min; gel extraction and ligation, 2 hr plus overnight incubation; transformation, 3 hr;
colony PCR, 4 hr; preparation of samples for sequencing, 1.5 hr. Up to 4 samples can
comfortably be handled in parallel. However, caution should be exercised as scaling up
increases the risk of cross-contamination.
Abbreviations
cDNA complementary DNA
mRNA messenger RNA
PCR polymerase chain reaction
RACE rapid amplification of cDNA ends
SMART switching mechanism at the 5'-terminus of the RNA transcript
polyA+ poly-adenylated
RT reverse transcription
TR T cell receptor
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Figure 1. Schematic representation of the 5'-SMART-RACE PCR
During cDNA synthesis, an anchor of known sequence is incorporated into the 5’ end of
full-length mRNA transcripts. PolyA+ RNA is reverse transcribed from a modified
oligo(dT) primer. When the RT reaches the 5’ end of the RNA, its terminal transferase
activity adds a short deoxycytidine (dC) sequence. This dC sequence then hybridizes to the
G ribonucleotide sequence at 3’ end of the SMART oligonucleotide. The RT then jumps
strands to transcribe the 5’ portion of the SMART oligonucleotide. As the addition of
deoxycytidine nucleotides is more efficient for full-length cDNA-RNA hybrids, full-length
products are selectively enriched. PCR is then performed on the single-stranded cDNA using
primers complementary to TRC genes of interest and the SMART oligonucleotide.
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Figure 2. Outline of well selection for checking colony PCR efficiency
From each of the highlighted wells, 5 µl of diluted PCR product is harvested and run on a
1% agarose gel with a 1 kb ladder. Bands should be visible at approximately 800 bp, while
the bottom right well (blue colony input) should yield a band at approximately 300 bp.
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Table 1
TR constant regions primers for use in RACE PCR
RM, rhesus macaque.
Species Gene Primer sequence (5’-3’) Primer
name
Human/RM TRBC TGCTTCTGATGGCTCAAACACAGCGACCT MBC2
Human TRAC GGAACTTTCTGGGCTGGGGAAGAAGGTGTCTTCTGG MAC2
RM TRAC AATAGGCAGACAGACTTGTCACTGGA 3CA3
Mouse TRBC TGGCTCAAACAAGGAGACCT MuMBC
Mouse TRAC TCAACTGGACCACAGCCTCAGCGTCA MuCalpha3
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